USA |NASDAQ |USD
Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
---|---|---|---|---|
- | Sep 30, 2021 | - | $0.22 | - |
Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
---|---|---|---|---|
- | Sep 30, 2021 | - | $0.00 | $0.00 |
Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
---|---|---|---|---|
Jun 30, 2021 | Jun 2021 | - | $0.22 | - |
Mar 31, 2021 | Mar 2021 | - | $-1.06 | - |
Mar 31, 2021 | Dec 2020 | - | $-1.06 | - |
Sep 30, 2020 | Jun 2020 | - | $-0.00 | - |
Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
---|---|---|---|---|
Mar 31, 2021 | Dec 2020 | - | $-1.06 | - |
Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
---|---|---|---|---|
Jun 30, 2021 | Jun 2021 | - | $0.00 | - |
Mar 31, 2021 | Mar 2021 | - | $0.00 | - |
Mar 31, 2021 | Dec 2020 | - | $0.00 | - |
Sep 30, 2020 | Jun 2020 | - | - | - |
Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
---|---|---|---|---|
Mar 31, 2021 | Dec 2020 | - | - | - |
Cm Life Sciences's previous earnings date was Jun 30, 2021 for its fiscal quarter ended Jun 30, 2021.
CMLF's earnings per share (EPS) was $0.22.
The EPS was higher than the previous fiscal quarter (Mar 2021) by -121.27%, and higher than the same period a year before (Jun 2020) by -22570.00%.
Revenues were $0.00.
The company reported a net income of $13.01M.
Free cash flow for the quarter was $-926.72K , compared to $-20.30K last quarter.
Cm Life Sciences's previous annual earnings date was Mar 31, 2021 for its fiscal year ended Dec 31, 2020.
CMLF's earnings per share (EPS) was $-1.06.
The company reported a net income of $-192.24K.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.